The GRAS acceptance follows on heels of recent FDA acknowledgement of a new dietary ingredient (NDI) notification for Superba krill oil.
FDA has accepted, with no objections, a self-affirmed Generally Recognized as Safe (GRAS) notification for Aker BioMarine’s (Oslo, Norway) Superba krill oil. As such, Superba krill oil is now deemed safe for use in food and beverage.
The GRAS acceptance follows on heels of recent FDA acknowledgement of a new dietary ingredient (NDI) notification for Superba krill oil.
Matts Johansen, the company’s executive vice president of sales and marketing, stated, “…Aker BioMarine Antarctic has developed an extensive safety dossier for Superba krill oil. The FDA’s earlier acknowledgement of our NDI notification was important for our existing and future customers to introduce Superba products in all supplement channels, while the new self-affirmed GRAS notice acceptance solidly opens the door to applications in the food and beverage industries as well.”
The phospholipid-bound eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in Superba krill oil are said to be highly bioavailable. The company says it is now actively exploring functional food applications in the United States.
Steve Mister on CRN's ongoing lawsuit against New York State
October 11th 2024Nutritional Outlook spoke to The Council for Responsible Nutrition's president and CEO, Steve Mister, at its annual meeting, Convergence '24. Mister discussed the latest in its ongoing lawsuit against NY State's law banning the sale of weight management and muscle building products to minors.